Global Nifedipine Extended Release Tablets Market Growth 2024-2030

By inhibiting the calcium channel on the cell membrane, slowing down the inflow of calcium ions, reducing the contractility of the heart and the oxygen consumption of the heart, thereby dilating the coronary arteries, increasing the blood supply to the heart, lowering blood pressure, improving the blood supply to the heart and reducing the burden on the heart. Because it is a sustained-release tablet, the drug is released at a controlled rate, allowing its effects to last for a period of time.

The global Nifedipine Extended Release Tablets market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Nifedipine Extended Release Tablets Industry Forecast” looks at past sales and reviews total world Nifedipine Extended Release Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Nifedipine Extended Release Tablets sales for 2024 through 2030. With Nifedipine Extended Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nifedipine Extended Release Tablets industry.

This Insight Report provides a comprehensive analysis of the global Nifedipine Extended Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nifedipine Extended Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nifedipine Extended Release Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nifedipine Extended Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nifedipine Extended Release Tablets.

United States market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Nifedipine Extended Release Tablets players cover:

• Valeant Pharmaceuticals
• Zydus Pharmaceuticals Inc
• Aurobindo Pharma LTD
• Pfizer Inc
• Sun Pharma Industries LTD

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine Extended Release Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by type:

• Original Drug
• Generic Drug

Segmentation by application:

• Hospital
• Pharmacy
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and its market penetration:

• Valeant Pharmaceuticals
• Zydus Pharmaceuticals Inc
• Aurobindo Pharma LTD
• Pfizer Inc
• Sun Pharma Industries LTD
• Osmotica Pharmaceuticals
• Alkem Laboratories Ltd.
• Novast Laboratories, LTD
• TWi Pharmaceuticals Inc.
• Shyndec Pharmaceutical Co., Ltd
• China National Pharmaceutical Industry Co., Ltd
• China Resource Pharmaceutical Group Co., Ltd
• Anglikang Pharmaceutical Co., Ltd
• Warrant Chiral Pharmaceutical Co., Ltd
• Tailison Pharmaceutical Co., Ltd
• Baheal Medical Inc.
• Bocheng Pharmaceutical Co., Ltd

Key Questions Addressed in this Report:

1. What is the 10-year outlook for the global Nifedipine Extended Release Tablets market?
2. What factors are driving Nifedipine Extended Release Tablets market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Nifedipine Extended Release Tablets market opportunities vary by end market size?
5. How does Nifedipine Extended Release Tablets break out by type, application?